ArticleFrontiers in public health2022

Globally optimal trial design and risk sharing arrangements are key to avoiding opportunity costs of delay and enabling equitable, feasible and effective global vaccine research and implementation in current or future pandemics.

Simon EckermannPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.